Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It certainly does Kainos, good morning mate...
Sounds good to me Dr M
Billy, I believe this is a very important RNS as it shows the potential going forward. It is also significant as it will change the sentiment of this share and bring new investors on board. If we see a new CEO in the next few weeks this will be great for us and SP.
Billyboy,
I agree that £80,000 is small fry, but such a small amount is very understandable, for what is actually a trial project for any buyer.
An apt saying might be, 'From small acorns, giant oaks grow'.
I first bought into RMS 2 years ago, and when I first looked at P2F, masks had not been thought of, so to me the mask issue was a bonus (although not as it turned out much of a bonus).
Looks like the start of the good news flow for Nanosynth....1st of many positive RNS's to hit us in the coming months giving holders a sustained increase in SP...... they pulled that one out of the hat....happy days...
“Nanoparticles are going to be revolutionary in fertiliser delivery and we can't wait to bring this fantastic product to the UK and European markets."
Billy boy 80k is nothing your right but it's the development and the potential as like the masks but this time let's hope they can market it with PIC properly. Standing by my 12 month hold this will be good as long as the BOD don't f.ck it up
GLA
Poor billy boy is upset his missed the 1p party
Never mind . Take some at 1.4p instead
Nanotechnology is the future and we are in a fantastic position with new products and 5 million in the bank!! Great news
Poor Jizzabell will be off to his food bank this morning
FANTASTIC news on this mornings RNS and the start of the news flow begins !!
Someone asked me last week how I expect us to get back to at least 2p. This is how :-) Good RNS. And one gets the feeling the beginning of a flow of good news for us. Well done all holders!
Boom!!!
Exactly Nina just as eg Heathrow Airport’s reevaluating theirs re what’s now available- normal PPE can’t cut the mustard or kill Covid - employers should absolutely be looking to get the very best available that actually merits the user wearing them not simply going through the motions. P2F masks kill Covid dead on contact and other nasty viruses too. Done. Employers have a duty of care and buying Prolarva masks means they are literally getting the world’s very best and safest masks for their staff and customers. That is an important separation between cheap Chinese mass production crap V patented innovative Covid killing medical grade masks. It shows their staff they really care if they have to make them wear masks each shift. It surely would inspire confidence too to their customers.
IMHO DYOR GLA
I think Dr Cave is commissioning three masts in Liverpool for this bigger boat that’s supposed to be launched. Just hope old Trevor is not the one flinging the champagne bottle and we have a new CEO to bless the boat and steer it in the right direction. Steer a heading of due north please helmsman, make haste, winter is around the corner:)
Jezebel, the careless attitude people have is what’s leading to increased numbers of cases week by week, but this concept is not a dead duck. More like a beautiful swan still growing. :)
I don’t blame the NHS and other businesses for wanting to use what they have purchased already for now (budget control) but I strongly believe they will soon review their purchase options and look at safer PPE going forward. Just like us invested here, everyone I have spoken to about this mask has been amazed by the concept. This baby will grow, but needs some more time and care. :)
It's time for a bit of realism folks! Mask users do not care whether it stops the virus, or kills it. It's academic and that is why it hasn't caught on these past months as a product. The posts here are really desperate , suggesting market strategies, board changes, advertising etc. The concept is a dead duck and the longer it takes you guys to accept that, the more money you will lose. I don't mean to be insensitive to those who are under water, but for goodness' sake don't drown!
Nina think your spot on , this will not turn around in the short term mainly down to pricing and lack of exposure . FDA will take ages even for emergency clearance you only have to look at Belluscura .
Longer term 12 months i still believe the tech behind the product will give us a profit with potentially new products . That's if the board actually use their funds wisely on decent marketing
GLA
Callit - agree of course USA FDA approval should increase the SP absolutely - what I meant was if that US/HK company can get it then there should be no barrier to P2F getting it too as ours is better way better imho and is also designed for surgical/medical professional use which the other isn’t it seems.
IMHO DYOR GLA
@callit.
May I also add that Pro-Larva has a higher filtration capacity than the American competitor alongside being cheaper. Theirs have tested 95% compared to over 98% for Pro-Larva.
@unitedguy.
Some great points made in your reply. One that stands out for me is the fact that Pro-Larva resides in a sea of cheap imported masks. This leads me to believe the statement by the BOD in the latest RNS that the price and the backlog of stock already available to NHS could prove difficult to sell our mask.
I don’t know about you, but observing people’s behaviour in public places I feel that they only wear a mask because they have to. The disposable ones that are meant to be changed every 2 hours are being used as reusable ones (people are crunching them up in their pockets and putting them back on throughout the day)
I am hoping that NHS and other private medical institutions will see sense and invest in better PPE once the current stock needs replacing.
Unfortunately every business is putting costs before safety at the moment. This is confirmed when managers try to keep quiet about an outbreak of covid in their hospitality establishments to avoid closing down even for 2 days (my sister works in a restaurant where this happened this week).
Short term this is very frustrating, but I still believe that long term RMS will be a great investment. I would personally prefer to see them licence the antiviral material rather then masks, but what do I know?!
Hi Sharebel.
You might be right. It may well be a forgone conclusion.
IMHO I still think if we get the RNS saying we have FDA approval it will be a positive thing for the SP. I'm not sure if all investors have priced this in at current levels?
I think the people buying that mask could well buy ours instead if it was available in the US. It does seem to indicate some demand for an antiviral mask.
We cost less than theirs and have actually tested our masks against the sars_cov_2 virus and as you say have the CE mark etc..
GLA DYOR
Time to go long now Herbie, short days are over.
Callitt - I see this as a foregone conclusion for P2F Prolarva to get FDA approval then considering that this company’s masks are not TYPE 11R surgical/medical grade. We also have the CE mark which they don’t mention so that co couldn’t sell in U.K. or Europe eg or any other country who relies on that certification as a bench of quality. This company seems to be simply targeting US public market not medical, surgical or industry. I think we sit head and shoulders above this!
IMHO DYOR GLA
I’ll buy some more in the morning Poorinvester
The only way is up right.
On thin I did wonder about that mask; It sounded to work quite a bit like ours with copper and zinc in it. If they got FDA approval I don't see why we couldn't?
That could shift the SP up maybe?